Clifford Chance
Healthcare & Life Sciences Update: The Netherlands - May 2015
8 May 2015
Companies active in the Dutch healthcare and life sciences sector are facing continuous regulatory changes. Recent changes include: an updated policy regarding the use of biosimilars, new policy rules on healthcare related administrative fines and a clarification on mandatory notifications when making use of Google Ads. This Healthcare & Life Sciences Update highlights some of the latest developments in regulations and enforcement which may impact your business.
